ISSN 0972-5997
Published Quarterly
Mangalore, India
editor.ojhas@gmail.com
 
Custom Search
 


OJHAS Vol. 23, Issue 2: April - June 2024

Short Report
Clinicopathologic Spectrum of Rosai Dorfman Disease through a Six-Case Series

Authors:
Kundhavai Chandrasekaran, Assistant Professor, Department of Pathology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Chengalpattu district, Tamilnadu, India,
Sandhya Sundaram, Professor, Department of Pathology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamilnadu, India,
Subalakshmi Balasubramanian, Associate Professor, Department of Pathology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamilnadu, India.

Address for Correspondence
Dr.Kundhavai Chandrasekaran,
Assistant Professor,,
Dpartment of Pathology,
Chettinad Hospital and Research Institute,
Chettinad Academy of Research and Education,
Kelambakkam, Chengalpattu district,
Tamilnadu, India.

E-mail: kundhavaipath@gmail.com.

Citation
Chandrasekaran K, Sundaram S, Balasubramanian S. Clinicopathologic Spectrum of Rosai Dorfman Disease through a Six-Case Series. Online J Health Allied Scs. 2024;23(2):10. Available at URL: https://www.ojhas.org/issue90/2024-2-10.html

Submitted: May 5, 2024; Accepted: Jul 10, 2024; Published: Jul 30, 2024

 
 

Abstract: Background: Rosai-Dorfman disease (RDD), or Sinus histiocytosis with massive lymphadenopathy, is a rare idiopathic disorder characterized by histiocytic proliferation. While lymph node involvement is predominant, extranodal manifestations pose diagnostic challenges, and only limited cases involving the breast have been reported. Methods: We present a series of RDD cases, including two in cervical nodes, one in perisplenic and aortocaval nodes, one in retroperitoneal nodes, one in the breast, and one in the nasopharynx. Clinical and histopathological features are examined to enhance our understanding of this complex disorder. Discussion: Comparison with literature reveals RDD predominantly affecting young and middle-aged individuals, with nodal involvement more prevalent than extranodal. Clinical and imaging challenges in extranodal cases underscore the importance of accurate diagnosis through histopathological and immunohistochemical analyses. Successful outcomes with various treatment modalities reaffirm the manageable nature of RDD. Conclusion: This series contributes to understanding RDD's varied clinical presentations, diagnostic intricacies, and successful management outcomes. Increased awareness, especially regarding rare extranodal involvements such as the breast, is crucial for accurate diagnosis and optimal therapeutic interventions.
Key Words: Rosai-Dorfman disease, Sinus histiocytosis, lymphadenopathy, extranodal

Introduction

Rosai Dorfman disease, or Sinus histiocytosis with massive lymphadenopathy, is a rare idiopathic condition characterized by the proliferation of histiocytes. While lymph node involvement is the more common presentation (60%), extranodal manifestations (40%) (1,2) are also observed. This series outlines cases involving cervical nodes, perisplenic and aortocaval nodes, retroperitoneal nodes, breast, and nasopharynx.

Rosai Dorfman - Nodal Presentation:

Four cases (Table 1) demonstrated enlarged lymph nodes: a 4-year-old with cervical lymphadenopathy, a 31-year-old with autoimmune hemolytic anemia and abdominal lymphadenopathy, a 72-year-old male with painless lymphadenopathy, and a 71-year-old male with abdominal pain and retroperitoneal node enlargement. Neutrophilic leukocytosis, elevated ESR, and biopsy findings of sinus dilation, histiocytes with emperipolesis (Figure 1, Figure 2), and positive S100 (Figure 4) and CD68(Figure 5) staining were consistent.



Figure 1 : Lymph node - Sheets of histiocytes with emperipolesis (40 x) Figure 2 : Lymph node - Sheets of histiocytes with emperipolesis (100 x)

Figure 3: Breast - Sheets of histiocytes with emperipolesis (400x)


Figure 4: Lymph node - Immunohistochemistry for S100 - Positive in the histiocytes Figure 5: Lymph node - Immunohistochemistry for CD68 - Positive in the histiocytes


Table 1: Clinicopathologic spectrum of Rosai Dorfman disease

S.No

Age /Sex

Clinical Presentation

Location

1

4/M

Painless lymphadenopathy

Cervical node

2

31/F

Painless lymphadenopathy

Abdominal node

3

73/M

Painless lymphadenopathy

Cervical node

4

71/M

Abdominal pain

Retroperitoneal node

5

42/F

Breast lump

Breast mass

6

16/F

Difficulty in breathing

Nasopharyngeal mass

Rosai Dorfman - Extranodal Presentation:

Two cases (Table 1) manifested extranodally: a 42-year-old with a breast lump and a 14-year-old with involvement of the nasopharynx and cervical nodes. Both cases exhibited histological features of Rosai Dorfman, including emperipolesis (Figure 3), positive S100 and CD68 staining. Imaging of extranodal presentations often mimicked malignancy.

Discussion:

Rosai-Dorfman disease, recognized as Sinus histiocytosis with massive lymphadenopathy, is an uncommon yet distinctive disorder characterized by the proliferation of histiocytes. While it most commonly presents with lymph node involvement (60%), approximately 40% of cases exhibit extranodal [1,2] manifestations. The extra nodal sites involved are nasal cavity, oral cavity, pharynx, paranasal sinuses, salivary glands, trachea, orbit, bone and skin[3]. Breast involvement is very rare - only 20 cases have been reported in literature.

In the nodal presentation subset, four distinct cases showcased enlarged lymph nodes, each presenting with unique clinical features. A 4-year-old male exhibited cervical lymphadenopathy, emphasizing the potential occurrence of Rosai-Dorfman in pediatric populations. The second case involved a 31-year-old female with a history of autoimmune hemolytic anemia and abdominal lymphadenopathy, presenting a diagnostic challenge due to its association with an underlying autoimmune condition. Additionally, two elderly males, ages 72 and 71, presented with painless lymphadenopathy and abdominal pain, respectively, further illustrating the diverse clinical scenarios associated with this disorder.

Histopathological examination of the nodal cases revealed sinus dilation and a distinctive feature known as emperipolesis, where histiocytes engulf intact lymphocytes. These findings, coupled with elevated levels of neutrophilic leukocytosis and raised ESR, align with established characteristics of Rosai-Dorfman disease. Importantly, positive immunohistochemical staining for S100 and CD68 provided conclusive evidence for the diagnosis, reinforcing the reliability of these markers in confirming the presence of histiocytic infiltration.

The extranodal presentation subset featured two cases, one involving the breast and another the nasopharynx. The breast case, a 42-year-old female with a lump, underscored the rarity of Rosai-Dorfman involvement in this organ, with only a limited number of cases reported in the literature. The nasopharyngeal case, a 14-year-old female, presented with breathing difficulties, highlighting the potential challenges in diagnosing extranodal manifestations that may mimic malignancies.

Comparisons with existing literature reveal that Rosai-Dorfman predominantly affects young and middle-aged individuals, with a median age around 36 years in the present study. Furthermore, nodal involvement was more prevalent than extranodal, aligning with broader trends observed in similar investigations. Cervical and submandibular(4) lymphadenopathy remained the common presentation in nodal cases, with bilateral, massive, and painless involvement noted in the majority.

Blood investigations consistently demonstrated neutrophilic leukocytosis and elevated ESR (3,5,6). across cases, further corroborating the systemic inflammatory nature of Rosai-Dorfman disease. However, challenges in diagnosis persisted, in nodal cases lymphoma(7) was the close differential diagnosis clinically; and in extranodal cases where clinical suspicion often leaned toward malignancy (8) due to FDG avid lesions observed in imaging studies.

Histological differential diagnoses, such as Langerhan cell histiocytosis and Erdheim Chester disease(9), were considered, emphasizing the importance of accurate diagnosis through a combination of clinical, histopathological, and immunohistochemical assessments. Though S100 and CD68 was positive, Langerhan cell histiocytosis was ruled out histologically by the absence of eosinophils and Langerhans cells with nuclear grooves. Erdheim Chester disease was ruled out due to presence of emperipolesis, absence of touton giant cells and positivity of S100.

Treatment modalities for Rosai-Dorfman encompass corticosteroids, immunosuppressive drugs, or surgical removal (1). Notably, the majority of cases display favorable responses to treatment, and the recurrence rate remains low. This underscores the potential for successful management and emphasizes the importance of early and accurate diagnosis to guide appropriate therapeutic interventions.

Conclusion:

In conclusion, this discussion highlights the diverse clinical presentations of Rosai-Dorfman disease, ranging from nodal to extranodal involvement. The diagnostic challenges, especially in extranodal cases, underscore the importance of a comprehensive approach involving clinical correlation, histopathological examination, and immunohistochemical analysis. The rarity of breast involvement and the successful management outcomes reinforce the need for increased awareness and understanding of this intriguing histiocytic disorder.

References

  1. AlKuwaity KW, Alosaimi MH, Alsahlawi KT, et al. Unusual Presentation of Rosai-Dorfman Disease: Report of a Rare Case. Am J Case Rep. 2019;20:91‐96.
  2. Warpe BM, More SV. Rosai-Dorfman disease: A rare clinico-pathological presentation. Australas Med J. 2014;7(2):68‐72.
  3. di Dio F, Mariotti I, Coccolini E, Bruzzi P, Predieri B, Iughetti L. Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature. BMC Pediatr. 2016;16:62.
  4. Maia RC, de Meis E, Romano S, Dobbin JA, Klumb CE. Rosai-Dorfman disease: a report of eight cases in a tertiary care center and a review of the literature. Braz J Med Biol Res. 2015;48(1):6‐12.
  5. Zhu F, Zhang JT, Xing XW, et al. Rosai-Dorfman disease: a retrospective analysis of 13 cases. Am J Med Sci. 2013;345(3):200‐210.
  6. El Kohen A, Planquart X, Al Hamany Z, Bienvenu L, Kzadri M, Herman D. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): two case reports. Int J Pediatr Otorhinolaryngol. 2001;61(3):243‐247.
  7. Pinto DC, Vidigal Tde A, Castro Bd, Santos BH, ousa NJ. Rosai-Dorfman disease in the differential diagnosis of cervical lymphadenopathy. Braz J Otorhinolaryngol. 2008;74(4):632‐635.
  8. Delaney EE, Larkin A, MacMaster S, Sakhdari A, DeBenedectis CM. Rosai-Dorfman Disease of the Breast. Cureus. 2017;9(4):e1153.
  9. Morkowski JJ, Nguyen CV, Lin P, et al. Rosai-Dorfman disease confined to the breast. Ann Diagn Pathol. 2010;14(2):81‐87.
 

ADVERTISEMENT